肝X受体(liver X receptors，LXRs)包括LXRα(NR1H3)和LXRβ(NR1H2)两种亚型，对机体的生理活动尤其代谢过程具有重要的调节作用。近年研究发现，LXRs可通过调控一系列信号转导通路抑制癌细胞增殖、侵袭、诱导凋亡等进而影响前列腺癌、乳腺癌、肝癌、黑色素瘤、白血病等多种恶性肿瘤的发生发展，成为癌症治疗新靶点。因此本文主要就LXRs在癌症网络调控的研究进展进行综述。
Liver X receptors—a new target for cancer treatment
Liver X receptors (LXRs), including two subtypes of LXRα (NR1H3) and LXRβ (NR1H2), play an important role in regulating the physiological activities especially for metabolism of human body. Recent studies have further explored that LXRs might be one of new targets for cancer treatment because it could influence several cancer progression such as prostate cancer, breast cancer, liver cancer, melanoma, leukemia through inhibiting the proliferation and invasion and inducing the apoptosis of cancer cells. Therefore, this review will focus on the research progress of LXRs in regulatory network of cancer.